{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:59:47Z","timestamp":1791385187408,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jad.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T03:17:44Z","timestamp":1426216664000},"page":"149-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-6930","authenticated-orcid":false,"given":"Matej","family":"Stuhec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Munda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Svab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/cap.2007.0068","article-title":"Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit\/Hyperactivity Disorder Treatment Study (PATS)","volume":"17","author":"Abikoff","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib2","first-page":"324","article-title":"Neuropsychological impairments in adult attention deficit hyperactivity disorder: a literature review","volume":"23","author":"B\u00e1lint","year":"2008","journal-title":"Psychiatr. Hung."},{"key":"10.1016\/j.jad.2015.03.006_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","article-title":"Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline","volume":"15","author":"Banaschewski","year":"2006","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"121","key":"10.1016\/j.jad.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1542\/peds.2006-1880","article-title":"Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder and oppositional defiant disorder","volume":"2008","author":"Bangs","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00004583-199505000-00017","article-title":"Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Barrickman","year":"1995","journal-title":"J Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0149-2918(07)80083-X","article-title":"Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit\/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study","volume":"29","author":"Biederman","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00148581-200305120-00006","article-title":"Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder","volume":"5","author":"Biederman","year":"2003","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.jad.2015.03.006_bib9","first-page":"120","article-title":"A double-blind trial of bupropion in children with attention deficit disorder","volume":"23","author":"Casat","year":"1987","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2015.03.006_bib10","first-page":"143","article-title":"Clinical and neuropsychological effects of the novel antidepressant bupropion","volume":"24","author":"Clay","year":"1998","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.euroneuro.2012.11.012","article-title":"European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"23","author":"Coghill","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-13-237","article-title":"Long-acting methylphenidate formulations in the treatment of attention-deficit\/hyperactivity disorder: a systematic review of head-to-head studies","volume":"13","author":"Coghill","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00787-013-0421-y","article-title":"Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit\/hyperactivity disorder: results from a randomized, controlled trial","volume":"23","author":"Coghill","year":"2014","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","article-title":"Bupropion hydrochloride in attention deficit disorder with hyperactivity","volume":"35","author":"Conners","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry."},{"key":"10.1016\/j.jad.2015.03.006_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.euroneuro.2009.07.008","article-title":"Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: a placebo-controlled Italian study","volume":"19","author":"Dell\u2019Agnello","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/11314350-000000000-00000","article-title":"Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions","volume":"23","author":"Dell\u2019Agnello","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials. Control","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jad.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2009.0111","article-title":"Atomoxetine versus placebo in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany","volume":"21","author":"Dittmann","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib19","first-page":"237","article-title":"Deutsche Gesellschaft f\u00fcr Kinder- und Jugendpsychiatrie und \u2013psychotherapie. Leitlinien der Deutschen Gesellschaft f\u00fcr Kinder- und Jugendpsychiatrie und \u2013psychotherapie [Guidelines of the German Society for Child Adolescent Psychiatry, Psychotherapy]","author":"D\u00f6pfner","year":"2007","journal-title":"K\u00f6ln. Deutscher \u00c4rzte Verlag Hyperkinetische St\u00f6rungen. (F90) [Hyperkinetic disorders]"},{"key":"10.1016\/j.jad.2015.03.006_bib20","first-page":"678","article-title":"Using meta-analysis to compare the efficacy of medications for attention-deficit\/hyperactivity disorder in youths","volume":"34","author":"Faraone","year":"2009","journal-title":"P T."},{"key":"10.1016\/j.jad.2015.03.006_bib21","first-page":"4","article-title":"Comparing the efficacy of medications for ADHD using meta-analysis","volume":"8","author":"Faraone","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.jad.2015.03.006_bib22","first-page":"104","article-title":"The worldwide prevalence of ADHD: is it an American condition?","volume":"2","author":"Faraone","year":"2003","journal-title":"World Psychiatr."},{"key":"10.1016\/j.jad.2015.03.006_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","article-title":"A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes","volume":"71","author":"Faraone","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","article-title":"Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder","volume":"190","author":"Fayyad","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4088\/JCP.v69n0120","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit\/hyperactivity disorder","volume":"69","author":"Findling","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaac.2011.01.007","article-title":"Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit\/hyperactivity disorder","volume":"50","author":"Findling","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/cap.2006.0091","article-title":"A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit\/hyperactivity disorder","volume":"17","author":"Gau","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib28","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.109.3.e39","article-title":"A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"109","author":"Greenhill","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.chc.2007.11.004","article-title":"Attention deficit hyperactivity disorder in preschool children","volume":"17","author":"Greenhill","year":"2008","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.jad.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-244X-11-176","article-title":"Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis","volume":"11","author":"Hanwella","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/adc.2006.106864","article-title":"Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006","volume":"93","author":"Harpin","year":"2008","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"issue":"343","key":"10.1016\/j.jad.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u05f3s tool for assessing risk of bias in randomised trials","volume":"18","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2015.03.006_bib33","series-title":"Cochrane Collaboration: Cochrane Handbook For Systematic Reviews Of Interventions Chichester","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jad.2015.03.006_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/108705470400800202","article-title":"Efficacy and safety of atomoxetine in childhood attention-deficit\/hyperactivity disorder with comorbid oppositional defiant disorder","volume":"8","author":"Kaplan","year":"2004","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.jad.2015.03.006_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","article-title":"Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial","volume":"114","author":"Kelsey","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2015.03.006_bib36","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1542\/peds.2010-0825","article-title":"A double-blind, placebo-controlled study of atomoxetine in young children with ADHD","volume":"127","author":"Kratochvil","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2015.03.006_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00787-009-0042-7","article-title":"Atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia","volume":"19","author":"Martenyi","year":"2010","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-7547-3-5","article-title":"A review of the economic burden of ADHD","volume":"3","author":"Matza","year":"2005","journal-title":"Cost Eff. Resour. Alloc."},{"key":"10.1016\/j.jad.2015.03.006_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2431-12-78","article-title":"The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care","volume":"12","author":"McCarthy","year":"2012","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.jad.2015.03.006_bib40","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","article-title":"Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study","volume":"159","author":"Michelson","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib41","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","article-title":"Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study","volume":"108","author":"Michelson","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jad.2015.03.006_bib42","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1185\/03007990903316152","article-title":"Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit\/hyperactivity disorder","volume":"25","author":"Montoya","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2015.03.006_bib43","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jpepsy\/jsm022","article-title":"The economic impact of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"32","author":"Pelham","year":"2007","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.jad.2015.03.006_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","article-title":"The Texas Children\u05f3s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder","volume":"45","author":"Pliszka","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/adc.2005.087460","article-title":"Atomoxetine-induced electrocardiogram changes","volume":"91","author":"Rajesh","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jad.2015.03.006_bib48","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1185\/03007995.2014.904772","article-title":"Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine","volume":"30","author":"Roskell","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2015.03.006_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0166-4328(00)00291-6","article-title":"Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder\u2014the spontaneously hypertensive rat","volume":"117","author":"Russell","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2015.03.006_bib50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4088\/JCP.v63n1209","article-title":"Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit\/hyperactivity disorder","volume":"63","author":"Spencer","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00787-008-0725-5","article-title":"Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naive Swedish children and adolescents","volume":"18","author":"Svanborg","year":"2009","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archpsyc.60.2.204","article-title":"Development of new once-a-day formulation of methylphenidate for the treatment of attention-deficit\/hyperactivity disorder","volume":"60","author":"Swanson","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(97)11450-7","article-title":"Attention-deficit hyperactivity disorder and hyperkinetic disorder","volume":"351","author":"Swanson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2015.03.006_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/cap.2008.0154","article-title":"A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit\/hyperactivity disorder","volume":"19","author":"Takahashi","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.03.006_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","article-title":"A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD","volume":"44","author":"Weiss","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2015.03.006_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00002018-200326100-00006","article-title":"Cardiovascular effects of atomoxetine in children, adolescents and adults","volume":"26","author":"Wernicke","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.jad.2015.03.006_bib57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpedi.160.1.82","article-title":"Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit\/hyperactivity disorder","volume":"160","author":"Wilens","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.jad.2015.03.006_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.108.4.883","article-title":"Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit\/hyperactivity disorder","volume":"108","author":"Wolraich","year":"2001","journal-title":"Pediatrics"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T07:28:07Z","timestamp":1537774087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":57,"alternative-id":["S0165032715001330"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.03.006","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}